ENTITY

ProKidney (PROK US)

3
Analysis
Health CareUnited States
ProKidney Corp operates as a biotech company. The Company develops therapies that repairs and restores diseased kidneys using a patient's own cells and may prevent or delay dialysis or transplant. ProKidney serves customers worldwide.
more
bullishProKidney
19 Jan 2022 11:12Syndicated

The Nightcap from SPAC Track

Social Capital Suvretta Holdings Corp. III (DNAC: no warrants, common +0.01%) & ProKidney. Vishal Garg, founder and CEO of digital mortgage lender...

Logo
237 Views
Share
14 Jan 2022 12:03Syndicated

These Dealmakers will Make or Break SPACs in 2022

While a majority of SPAC dealmakers have faced issues such as raising adequate financing for deals or acquiring high-quality merger targets, Serial...

Logo
subSPAC
507 Views
Share
bullishProKidney
10 Jan 2022 11:38Syndicated

The Nightcap from SPAC Track

Exactly one year to the day after Chamath Palihapitiya’s last SPAC deal announcement, we have news that one of his four biotech SPACs is in talks...

Logo
269 Views
Share
No more insights
x